Versigent (NYSE:VGNT) Given Average Recommendation of “Moderate Buy” by Brokerages

Versigent (NYSE:VGNT) has received a consensus recommendation of “Moderate Buy” from the eleven brokerages that are covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $46.6667.

Several equities research analysts have issued reports on the company. Royal Bank Of Canada assumed coverage on Versigent in a report on Tuesday, March 31st. They set a “sector perform” rating and a $28.00 price target for the company. Fox Advisors raised Versigent to a “strong-buy” rating in a report on Tuesday, April 7th. Wells Fargo & Company raised their price target on Versigent from $35.00 to $42.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. BNP Paribas Exane assumed coverage on Versigent in a report on Tuesday, April 28th. They set an “outperform” rating and a $41.00 price target for the company. Finally, Wall Street Zen raised Versigent to a “hold” rating in a report on Saturday, April 18th.

Versigent Price Performance

Shares of Versigent stock opened at $47.39 on Friday. The firm’s fifty day simple moving average is $38.67. Versigent has a 1 year low of $26.34 and a 1 year high of $50.66.

Versigent (NYSE:VGNT) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $999.00 earnings per share (EPS) for the quarter.